Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Mursla Bio, a Cambridge, UK-based company that focuses on EV isolation, biomarker discovery from EV cargo, and EV assays for clinical use, is an EVEREST participant.
ARPA-H Awards $110M to Commercial, Academic Teams Tackling Women's Health
The awardees included several diagnostics firms, among them Aspira Women's Health, which received $10 million for development of its EndoMDx test.
The letter encourages drug developers to "further study and use" αSyn-SAA testing for selecting patients for clinical trials for Parkinson's and related diseases.
NIH Awards $2.4M to Improve Syphilis Diagnostics
The 10 awards cover different novel diagnostic approaches as well as biomarker discovery and pre-analytical methods.
BioAI, Genomic Testing Cooperative Collaborate to Support Pharmas, Clinicians
The companies will leverage their joint AI capabilities to advance biomarker development and both tissue and liquid biopsy genomic profiling assays.